Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 4 43-4, 1998, Pages

  Vaziri, N D ^a,b   Ni, Z ^a   Wang, X Q ^a   Oveisi, F ^a   Zhou, X J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anemia; Blood pressure; Calcium channel blockers; Endothelial derived relaxing factor; Hypertension; Parathyroid hormone; Uremia

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CALCIUM CELL LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; MALE; NONHUMAN; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ARTERY; THORACIC AORTA; URINARY EXCRETION;

EID: 0031968667     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.274.4.f642     Document Type: Article

References (33)

1. Aiello, S., M. Noris, D. Corna, A. Benigni, C. Zoja, M. Todeschini, and G. Remuzzi. Defective renal synthesis of nitric oxide (NO) in rats with reduced renal mass (RMR) (Abstract). J. Am. Soc. Nephrol. 5: 936, 1994.
2. Aiello, S., M. Noris, M. Todeschini, S. Zappella, C. Foglini, A. Benigni, D. Corna, C. Zoja, D. Cavallotti, and G. Remuzzi. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int. 50: 171-181, 1997.
3. Akmal, M., S. E. Kasim, A. R. Soliman, and S. G. Massry. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int. 37: 854-858, 1990.
4. Awolesi, M. A., W. C. Sessa, and B. E. Sumpio. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J. Clin. Invest. 96: 1445-1449, 1995.
5. Braman, R. S., and S. A. Hendrix. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal. Chem. 61: 2715-2718, 1989.
6. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J. Hypertens. 10: 1025-1031, 1992.
7. Coma, D., M. Noris, E. Luzzana, A. Benigni, C. Zoja, M. Todeschini, and G. Remuzzi. A nitric oxide (NO) donor either as prophylaxis or therapy slows renal disease progress and prolongs survival in remnant kidneys (Abstract). J. Am. Soc. Nephrol. 7: 1852, 1996.
8. Comini, L., T. Bachetti, G. Gaia, E. Pasini, L. Agnoletti, P. Pepi, C. Ceconi, S. Curello, and R. Ferrari. Aorta and skeletal muscle NO synthase expression in experimental heart failure. Mol. Cell. Cardiol. 28: 2241-2248, 1996.
9. Fernandez, M., J. C. Garcia-Pacan, M. Casadevall, C. Bernadich, C. Piera, B. J. R. Whittle, and J. M. Pique. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 108: 1487-1495, 1995.
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
11. Karaki, H. Calcium localization and sensitivity in vascular smooth muscle. Trends Pharmacol. Sci. 10: 320-325, 1989.
12. Klin, M., M. Smogorzewski, Z. Ni, G. Zhang, and S. G. Massry. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J. Clin. Invest. 97: 2167-2173, 1996.
13. Lincoln, T. M., and T. L. Cornwell. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 28: 129-137, 1991.
14. Luscher, T. F. The endothelium. Target and promoter of hypertension? Hypertension 15: 482-485, 1990.
15. MacAllister, R., and P. Vallance. Nitric oxide in essential and renal hypertension. J. Am. Soc. Nephrol. 5: 1057-1065, 1994.
16. MacAllister, R. J., G. S. J. Whitley, and P. Vallance. Effect of guanidino and uremic toxins on nitric oxide systems. Kidney Int. 45: 737-742, 1994.
17. Marletta, M. A. Nitric oxide: biosynthesis and biological significance. Trends Biochem. Sci. 14: 488-492, 1989.
18. Martin, P. Y., D. L. Xu, M. Niederberger, A. Weigert, P. Tsai, J. St. John, P. Gines, and R. W. Schrier. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F494-F499, 1996.
19. Massry, S. G., M. Klin, Z. Ni, J. Tian, L. Kedes, M. Smogorzewski. Impaired agonist-induced calcium signaling in hepatocytes from chronic renal failure rats. Kidney Int. 48: 1324-1331, 1995.
20. Moncada, S., and E. A. Higgs. Molecular mechanism and therapeutic strategies related to nitric oxide. FASEB J. 9: 1319-1330, 1995.
21. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
22. Nava, E., and T. F. Luscher. Evidence for an increased production of nitric oxide in spontaneously hypertensive rats (Abstract). Eur. J. Clin. Invest. 24, Suppl. 2: A264, 1994.
23. Ni, Z., S. Morcos, and N. D. Vaziri. Upregulation of renal and vascular nitric oxide synthase in iron-deficiency anemia. Kidney Int. 52: 195-201, 1997.
24. Noris, M., A. Benigni, P. Boccardo, S. Aiello, F. Gaspari, M. Todeschini, M. Figliuzzi, and G. Remuzzi. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int. 44: 445-450, 1993.
25. Noris, M., M. Morigi, R. Donadelli, S. Aiello, M. Foppolo, M. Todeschini, S. Orisio, G. Remuzzi, and A. Remuzzi. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ. Res. 76: 536-543, 1995.
26. Panes, J., M. Casadevall, J. M. Pique, J. Bosch, B. J. R. Whittle, and J. Teres. Effects of acute normovolemic anemia on gastric mucosa blood flow in rats: role of nitric oxide. Gastroenterology 103: 407-413, 1992.
27. Panza, J. A., P. R. Casino, C. M. Kilcoyne, and A. A. Quyyumi. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87: 1468-1474, 1993.
28. Pohl, U., J. Holtz, R. Busse, and E. Bassenge. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8: 37-44, 1986.
29. Remuzzi, G., N. Perico, C. Zoja, D. Macconi, and G. Vigano. Role of endothelium-denved nitric oxide in the bleeding tendency of uremia. J. Clin. Invest. 86: 1768-1771, 1990.
30. Vallance, P., A. Leone, A. Calver, J. Collier, and S. Moncada. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992.
31. Vaziri, N. D., X. Q. Wang, and K. Liang. Role of secondary hyperparathyroidism in the pathogenesis of depressed lipoprotein lipase expression in chronic renal failure. Am. J. Physiol. 273 (Renal Fluid Electrolyte Physiol. 42): F925-F930, 1997.
32. Vaziri, N. D., X. J. Zhou, F. Naqvi, J. Smith, F. Oveisi, Z. Q. Wang, and R. E. Purdy. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E113-E122, 1996.
33. Vaziri, N. D., X. J. Zhou, J. Smith, F. Oveisi, K. Baldwin, and R. E. Purdy. In vivo and in vitro pressor effects of erythropoietin in rats. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F838-F845, 1995.